A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus-Reference-Cited by-同舟云学术

A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus

Published:2011-04-26 Issue:4 Volume:6 Page:e18995
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Martina Byron E. E.,van den Doel Petra,Koraka Penelope,van Amerongen Geert,Spohn Gunther,Haagmans Bart L.,Provacia Lisette B. V.,Osterhaus Albert D. M. E.,Rimmelzwaan Guus F.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.;F Mostashari;Lancet,2001

2. Human T-cell clones in long-term culture as a model of immunosenescence.;G Pawelec;Immunol Rev,1997

3. Admission criteria for immunogerontological studies in man: the SENIEUR protocol.;GJ Ligthart;Mech Ageing Dev,1984

4. Lessons from 40 years' surveillance of influenza in England and Wales.;DM Fleming;Epidemiol Infect,2008

5. The continuing spread of West Nile virus in the western hemisphere.;DJ Gubler;Clin Infect Dis,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice;Vaccine: X;2024-10

2. A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice;Virus Research;2024-07

3. Intranasal bivalent vaccine with recombinant Influenza Virus expressing Pneumococcal Surface Protein A (PspA) protects against Streptococcus pneumoniae and Influenza A virus infection in mice;2024-04-02

4. Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets;Journal of Virology;2023-11-30

5. Single-Dose Intranasal Immunisation with Novel Chimeric H1N1 Expressing the Receptor-Binding Domain of SARS-CoV-2 Induces Robust Mucosal Immunity, Tissue-Resident Memory T Cells, and Heterologous Protection in Mice;Vaccines;2023-09-04